Correction of neutropenia and hypogammaglobulinemia in X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation

Bone Marrow Transplantation

Volumn 22, Issue 12, 1998, Pages 1215-1218

  Scholl, P R ^a,b   O'Gorman, M R G ^a   Pachman, L M ^a   Haut, P ^a   Kletzel, M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Children's Memorial Institute for Education and Research   (United States)

Author keywords

Bone marrow transplantation; Immunologic deficiency syndromes; Mutation; Neutropenia

Indexed keywords

GLYCOPROTEIN GP 39; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN M;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; CELLULAR IMMUNITY; GENE MUTATION; HUMAN; HUMORAL IMMUNITY; HYPERGAMMAGLOBULINEMIA; HYPERIMMUNOGLOBULINEMIA; IMMUNE DEFICIENCY; MALE; NEUTROPENIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SPLICING; SUPERINFECTION; T LYMPHOCYTE;

EID: 0032436402     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701512     Document Type: Article

References (21)

1. Levy J, Espanol-Boren T, Thomas C et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997; 131: 47-54.
2. Allen RC, Armitage RJ, Conley ME et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993; 259: 990-993.
3. DiSanto JP, Bonnefoy JY, Gauchat JF et al. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 1993; 361: 541-543.
4. Korthauer U, Graf D, Mages HW et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 1993; 361: 539-541.
5. Aruffo A, Farrington M, Hollenbaugh D et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 1993; 72: 291-300.
6. Fuleihan R, Ramesh N, Loh R et al. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci USA 1994; 90: 2170-2173.
7. Foy T, Aruffo A, Bajorath J et al. Immune regulation by CD40 and its ligand gp39. Ann Rev Immunol 1996; 14: 591-617.
8. Rosen F, Cooper M, Wedgwood R. Medical progress: the primary immunodeficiencies. New Engl J Med 1995; 333: 431-440.
9. Banatvala N, Davies J, Kanariou M et al. Hypogammaglobulinaemia associated with normal or increased IgM (the hyper IgM syndrome): a case series review. Arch Dis Child 1994; 71: 150-152.
10. Wang WC, Cordoba J, Infante AJ, Conley ME. Successful treatment of neutropenia in the hyper-immunoglobulin M syndrome with granulocyte colony-stimulating factor. Am J Fed Hematol Oncol 1994; 16: 160-163.
11. Duplantier J, Nelson R, Ochs H et al. Successful bone marrow transplantation (BMT) for X-linked hyper IgM (XHIM) syndrome. J Allergy Clin Immunol 1997; 99: S102.
12. Buckley R. Transplantation. In: Stiehm E (ed). Immunologic Disorders in Infants and Children, 4th edn. WB Saunders: Philadelphia, 1996, pp 1014-1058.
13. Thomas C, de Saint Basile G, Le Deist F et al. Brief report: correction of X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation. New Engl J Med 1995; 333: 426-429.
14. O'Gorman MRG, Zaas D, Paniagua M et al. Development of a rapid whole blood flow cytometry procedure for the diagnosis of X-linked hyper-IgM syndrome patients and carriers. Clin Immunol Immunopathol 1997; 85: 172-181.
15. Lin Q, Rohrer J, Allen RC et al. A single strand conformation polymorphism study of CD40 ligand. Efficient mutation analysis and carrier detection for X-linked hyper IgM syndrome. J Clin Invest 1996; 97: 196-201.
16. Hollenbaugh D, Wu LH, Ochs HD et al. The random inactivation of the X chromosome carrying the defective gene responsible for X-linked hyper IgM syndrome (X-HIM) in female carriers of HIGM1. J Clin Invest 1994; 94: 616-622.
17. Krawczak M, Reiss J, Cooper D. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 1992; 90: 41-54.
18. Nonoyama S, Shimadzu M, Toru H et al. Mutations of the CD40 ligand gene in 13 Japanese patients with X-linked hyper-IgM syndrome. Hum Genet 1997; 99: 624-627.
19. Villa A, NotarangeIo LD, Di Santo JP et al. Organization of the human CD40L gene: implications for molecular defects in X chromosome-linked hyper-IgM syndrome and prenatal diagnosis. Proc Natl Acad Sci USA 1994; 91: 2110-2114.
20. Vassal G, Challine D, Koscielny S et al. Chronopharmacology of high-dose busulfan in children. Cancer Res 1993; 53: 1534-1537.
21. Grochow LB, Krivit W, Whitley CB, Blazar B. Busulfan disposition in children. Blood 1990; 75: 1723-1727.